Actions by the US drug regulator impacts Indian manufacturers, who generate significant revenue by selling copycat drugs at a fraction of the cost in the world#39;s largest market for medicinesfrom Moneycontrol Business News https://www.moneycontrol.com/news/business/commissioner-scott-gottlieb-exits-usfda-indian-firms-curiousagency39s-future-course_12223561.html
No comments:
Post a Comment